Chapter 13. Chemotherapy in Hormone Refractory Prostate Cancer

  1. Jonathan Waxman BSc, MD, MBBS, FRCP
  1. J. J. Knox and
  2. M. J. Moore

Published Online: 21 JAN 2008

DOI: 10.1002/9780470757147.ch13

Treatment Options in Urological Cancer

Treatment Options in Urological Cancer

How to Cite

Knox, J. J. and Moore, M. J. (2002) Chemotherapy in Hormone Refractory Prostate Cancer, in Treatment Options in Urological Cancer (ed J. Waxman), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470757147.ch13

Editor Information

  1. Department of Cancer Medicine, Imperial College of Science, Technology and Medicine, London

Publication History

  1. Published Online: 21 JAN 2008
  2. Published Print: 1 JAN 2002

ISBN Information

Print ISBN: 9780632055890

Online ISBN: 9780470757147

SEARCH

Keywords:

  • hormone refractory prostate cancer;
  • chemotherapy;
  • hormonal therapies.;
  • cytotoxic chemotherapy;
  • mitoxantrone

Summary

This chapter contains sections titled:

  • Introduction

  • Definition of hormone refractory prostate cancer (HRPC)

  • Supportive treatments

  • Evaluation of the response and benefits of therapy

  • Older studies of chemotherapy

  • Mitoxantrone plus prednisone

  • Suramin

  • Novel targets for therapy

  • Chemotherapy in earlier stage prostate cancer

  • Conclusion